Strainsforpains, Inc. (EBYH)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Strainsforpains, Inc. (EBYH) with AI Score 57/100 (Hold). Strainsforpains, Inc. is a medical marijuana data recommendation system, offering the Strainsforpains app to connect patients with suitable cannabis strains based on personal data and genetics. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 17, 2026Strainsforpains, Inc. (EBYH) Healthcare & Pipeline Overview
Strainsforpains, Inc. operates a medical marijuana data recommendation system, leveraging its Strainsforpains app to match patients with appropriate cannabis strains based on personal data and genetics. Serving medical specialists, dispensaries, and consumers, the company aims to enhance treatment efficacy within the evolving medical cannabis market.
Investment Thesis
Strainsforpains, Inc. presents a unique investment opportunity within the rapidly expanding medical cannabis market. The company's Strainsforpains app addresses a critical need for personalized treatment recommendations, potentially driving user adoption and revenue growth. However, the company's negative profit margin of -819.6% and a P/E ratio of -17.76 indicate significant financial challenges. Successful scaling of the user base and strategic partnerships with medical specialists and dispensaries are crucial for achieving profitability. The company's beta of -0.12 suggests low volatility relative to the market, but this may also reflect limited trading activity and investor interest. The absence of a dividend further underscores the company's focus on reinvesting earnings for growth.
Based on FMP financials and quantitative analysis
Key Highlights
- Operates as a medical marijuana data recommendation system, offering the Strainsforpains app.
- Serves medical specialists, dispensaries, and consumers, providing data-driven insights for cannabis strain selection.
- Incorporated in 1990, indicating a long-standing presence in the evolving medical cannabis market.
- Based in New York City, positioning it within a key geographic market for the medical cannabis industry.
- Reports a negative profit margin of -819.6%, highlighting the need for improved financial performance.
Competitors & Peers
Strengths
- Proprietary data-driven approach to cannabis strain recommendation.
- Established presence in the medical cannabis market since 1990.
- Potential for strong network effects as user base grows.
- Serves multiple customer segments (medical specialists, dispensaries, consumers).
Weaknesses
- Negative profit margin (-819.6%) indicates financial instability.
- Limited brand recognition compared to larger players in the cannabis industry.
- Reliance on evolving regulations and acceptance of medical cannabis.
- Unknown disclosure status on the OTC market.
Catalysts
- Ongoing: Increasing acceptance and legalization of medical cannabis in new jurisdictions.
- Ongoing: Growing demand for personalized treatment recommendations in the medical cannabis market.
- Upcoming: Potential partnerships with medical specialists and healthcare providers.
- Upcoming: Development of new features and functionalities for the Strainsforpains app.
Risks
- Ongoing: Intense competition from established cannabis companies and new entrants.
- Potential: Changes in regulations or public perception of medical cannabis.
- Potential: Data breaches or privacy concerns related to user data.
- Ongoing: The company's negative profit margin and financial instability.
- Potential: Economic downturns impacting consumer spending on discretionary healthcare products.
Growth Opportunities
- Expansion into new geographic markets represents a significant growth opportunity for Strainsforpains, Inc. As medical cannabis legalization continues to spread across the United States and internationally, the company can leverage its data-driven platform to serve patients and healthcare providers in new regions. This expansion could involve strategic partnerships with local dispensaries and medical facilities, as well as targeted marketing campaigns to raise awareness of the Strainsforpains app. The timeline for this expansion will depend on the pace of regulatory changes and the company's ability to secure the necessary licenses and permits.
- Developing strategic partnerships with medical specialists and healthcare providers can drive increased adoption of the Strainsforpains app. By integrating the app into clinical workflows and providing healthcare professionals with access to data-driven insights, the company can establish itself as a trusted resource within the medical community. This collaboration could involve joint research initiatives, educational programs, and the development of customized solutions for specific patient populations. The timeline for establishing these partnerships will depend on the company's ability to demonstrate the clinical value of its platform and build strong relationships with key stakeholders.
- Enhancing the Strainsforpains app with additional features and functionalities can attract new users and increase engagement among existing users. This could include incorporating patient feedback, integrating with wearable devices to track physiological responses to different cannabis strains, and developing personalized treatment plans based on individual patient profiles. The timeline for implementing these enhancements will depend on the company's ability to gather and analyze user data, as well as its capacity to develop and deploy new software features. The market for mobile health applications is expected to reach $68 billion by 2028, providing a significant opportunity for Strainsforpains, Inc. to capitalize on this trend.
- Exploring opportunities to license its data and technology to other companies within the medical cannabis industry can generate new revenue streams and expand the company's reach. This could involve partnering with cannabis cultivators, manufacturers, and retailers to provide them with access to the Strainsforpains app's data and algorithms. The timeline for securing these licensing agreements will depend on the company's ability to demonstrate the value of its data and technology, as well as its capacity to negotiate favorable terms. The market for cannabis data and analytics is expected to grow significantly in the coming years, driven by the increasing demand for data-driven insights within the industry.
- Expanding the Strainsforpains app's database to include a wider range of cannabis strains and products can improve the accuracy and relevance of its recommendations. This could involve collaborating with cannabis breeders, cultivators, and manufacturers to gather data on new and existing strains, as well as incorporating user feedback to refine the app's algorithms. The timeline for expanding the database will depend on the company's ability to establish relationships with industry stakeholders and implement efficient data collection processes. A more comprehensive database will enhance the app's ability to provide personalized recommendations and improve patient outcomes.
Opportunities
- Expansion into new geographic markets as medical cannabis legalization spreads.
- Strategic partnerships with medical specialists and healthcare providers.
- Development of new features and functionalities for the Strainsforpains app.
- Licensing of data and technology to other companies in the cannabis industry.
Threats
- Increasing competition from established cannabis companies and new entrants.
- Changes in regulations or public perception of medical cannabis.
- Potential for data breaches or privacy concerns.
- Economic downturns impacting consumer spending on discretionary healthcare products.
Competitive Advantages
- Proprietary algorithm for matching patients with cannabis strains based on personal data and genetics.
- Established user base and brand recognition within the medical cannabis community.
- Data network effects, as the app's recommendations improve with increased user data.
About EBYH
Strainsforpains, Inc., established in 1990 and headquartered in New York City, operates as a medical marijuana data recommendation system. The company's core offering is the Strainsforpains app, a user-based application designed to scientifically determine the most suitable cannabis brand or strain for patients. This determination is based on a combination of personal data provided by the user and the genetic characteristics of various cannabis strains. The app aims to bridge the gap between patients seeking medical cannabis treatments and the vast array of available products, ensuring a more personalized and effective treatment experience. Strainsforpains, Inc. caters to a diverse clientele, including medical specialists who can utilize the app to inform their treatment recommendations, dispensaries seeking to provide tailored product suggestions to their customers, and individual consumers looking for guidance in navigating the medical cannabis market. By providing data-driven insights, Strainsforpains, Inc. aims to improve patient outcomes and promote responsible use of medical cannabis. The company's focus on personalized recommendations and data-driven decision-making positions it within the burgeoning healthcare information services sector, specifically catering to the medical cannabis industry.
What They Do
- Develops the Strainsforpains app, a user-based application.
- Scientifically determines which cannabis brand or strain is right for patients.
- Bases recommendations upon personal data and strain genetics.
- Serves medical specialists by providing data-driven insights.
- Serves dispensaries by enabling tailored product suggestions.
- Serves consumers by guiding them in navigating the medical cannabis market.
Business Model
- Generates revenue through user subscriptions to the Strainsforpains app.
- Partnerships with dispensaries for premium placement and data analytics.
- Licensing of its data and technology to other companies in the cannabis industry.
Industry Context
Strainsforpains, Inc. operates within the rapidly evolving medical cannabis industry, a sector characterized by increasing legalization, growing patient acceptance, and expanding product offerings. The market is driven by the potential therapeutic benefits of cannabis for various medical conditions. The competitive landscape includes companies like AGTX, CSOC, EWLL, HESG, and ICCO, some of which may offer overlapping or complementary services. Strainsforpains, Inc.'s success depends on its ability to differentiate itself through its data-driven approach and establish strategic partnerships within the healthcare ecosystem.
Key Customers
- Medical specialists seeking data-driven insights for treatment recommendations.
- Dispensaries aiming to provide tailored product suggestions to customers.
- Individual consumers looking for guidance in navigating the medical cannabis market.
Financials
Chart & Info
Strainsforpains, Inc. (EBYH) stock price: Price data unavailable
Latest News
No recent news available for EBYH.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for EBYH.
Price Targets
Wall Street price target analysis for EBYH.
MoonshotScore
What does this score mean?
The MoonshotScore rates EBYH's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Yeshua Simon Shainberg
CEO
Yeshua Simon Shainberg serves as the CEO of Strainsforpains, Inc. His professional background reflects a commitment to innovation within the healthcare and technology sectors. While detailed biographical information is limited, his leadership role suggests experience in guiding technology-driven solutions within the medical field. His expertise likely encompasses strategic planning, product development, and market positioning within the evolving medical cannabis industry. He is responsible for steering the company's vision and growth strategy.
Track Record: Due to limited information, Yeshua Simon Shainberg's specific achievements and strategic decisions at Strainsforpains, Inc. cannot be comprehensively assessed. However, under his leadership, the company continues to operate the Strainsforpains app, aiming to connect patients with suitable cannabis strains. His focus is likely on navigating the complex regulatory landscape and fostering partnerships to expand the company's reach and impact within the medical cannabis market.
EBYH OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Strainsforpains, Inc. may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting, and investors should exercise caution due to the increased risk of fraud and manipulation. This tier is often populated by shell companies, defunct businesses, or companies with questionable operations. Investing in OTC Other stocks carries significant risks compared to stocks listed on major exchanges like the NYSE or NASDAQ, due to less stringent regulatory oversight and reporting requirements.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases the risk of investing in EBYH.
- Low trading volume and wide bid-ask spread can lead to price volatility and difficulty in executing trades.
- The OTC Other tier carries a higher risk of fraud and manipulation.
- The company's financial viability is uncertain given its negative profit margin.
- Regulatory changes in the medical cannabis industry could negatively impact the company's operations.
- Verify the company's registration and legal standing.
- Attempt to obtain and review any available financial statements.
- Assess the company's business model and competitive landscape.
- Evaluate the management team's experience and track record.
- Understand the regulatory environment for medical cannabis in the company's operating regions.
- Consult with a financial advisor before investing.
- Be aware of the risks associated with investing in OTC Other stocks.
- The company has been in operation since 1990, suggesting some level of historical presence.
- The Strainsforpains app serves a specific niche within the medical cannabis market.
- The company targets multiple customer segments (medical specialists, dispensaries, consumers).
Common Questions About EBYH
What does Strainsforpains, Inc. do?
Strainsforpains, Inc. operates as a medical marijuana data recommendation system, primarily through its Strainsforpains app. This application is designed to scientifically determine the most suitable cannabis brand or strain for patients based on their personal data and the genetic characteristics of various cannabis strains. The company serves medical specialists by providing data-driven insights to inform treatment recommendations, dispensaries by enabling tailored product suggestions for their customers, and individual consumers by guiding them in navigating the complex medical cannabis market. The company aims to improve patient outcomes and promote responsible use of medical cannabis through personalized recommendations.
What do analysts say about EBYH stock?
As of March 17, 2026, there is no readily available analyst coverage for Strainsforpains, Inc. (EBYH) due to its listing on the OTC Other market and its limited financial disclosure. Key valuation metrics such as revenue growth, earnings per share, and price targets are not available. Investors should conduct their own thorough research and due diligence before considering an investment in EBYH, taking into account the risks associated with OTC stocks and the lack of analyst insights. The company's growth potential depends on its ability to scale its user base, establish strategic partnerships, and navigate the evolving regulatory landscape of the medical cannabis industry.
What are the main risks for EBYH?
Investing in Strainsforpains, Inc. (EBYH) carries significant risks, primarily due to its listing on the OTC Other market and its limited financial disclosure. The company's negative profit margin of -819.6% indicates financial instability, and the lack of analyst coverage makes it difficult to assess its growth potential. Regulatory changes in the medical cannabis industry could negatively impact the company's operations, and increasing competition from established cannabis companies poses a threat to its market share. Additionally, data breaches or privacy concerns related to user data could damage the company's reputation and lead to legal liabilities. Investors should carefully consider these risks before investing in EBYH.
What are the key factors to evaluate for EBYH?
Strainsforpains, Inc. (EBYH) currently holds an AI score of 57/100, indicating moderate score. Key strength: Proprietary data-driven approach to cannabis strain recommendation.. Primary risk to monitor: Ongoing: Intense competition from established cannabis companies and new entrants.. This is not financial advice.
How frequently does EBYH data refresh on this page?
EBYH prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven EBYH's recent stock price performance?
Recent price movement in Strainsforpains, Inc. (EBYH) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Proprietary data-driven approach to cannabis strain recommendation.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider EBYH overvalued or undervalued right now?
Determining whether Strainsforpains, Inc. (EBYH) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying EBYH?
Before investing in Strainsforpains, Inc. (EBYH), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be limited due to the company's OTC listing and unknown disclosure status.
- AI analysis is pending and may provide further insights in the future.